Viewing StudyNCT06492304



Ignite Creation Date: 2024-07-17 @ 11:40 AM
Last Modification Date: 2024-10-26 @ 3:34 PM
Study NCT ID: NCT06492304
Status: RECRUITING
Last Update Posted: 2024-07-09
First Post: 2024-06-21

Brief Title: A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With RelapsedRefractory Hematologic Malignancies
Sponsor:
Organization: CRISPR Therapeutics